Cargando…
Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case
Although surgery represents the treatment of choice for the majority of basal cell carcinomas, different therapies are required to treat the advanced ones. Vismodegib and sonidegib are the two oral Smoothened (Smo) inhibitors approved for the treatment of advanced basal cell carcinoma. Clinical dete...
Autores principales: | Villani, Alessia, Fabbrocini, Gabriella, Costa, Claudia, Scalvenzi, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163916/ https://www.ncbi.nlm.nih.gov/pubmed/33856641 http://dx.doi.org/10.1007/s13555-021-00533-9 |
Ejemplares similares
-
Vismodegib treatment in advanced basal cell carcinomas: Real‐life experience
por: Villani, Alessia, et al.
Publicado: (2021) -
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
por: Scalvenzi, Massimiliano, et al.
Publicado: (2020) -
Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy
por: Villani, Alessia, et al.
Publicado: (2022) -
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test
por: Villani, Alessia, et al.
Publicado: (2019) -
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
por: Villani, Alessia, et al.
Publicado: (2020)